The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Response and adverse events to chemotherapy after prior checkpoint inhibition in lung cancer.
 
Julia Judd
No Relationships to Disclose
 
Chethan Ramamurthy
No Relationships to Disclose
 
Elizabeth Handorf
Research Funding - Pfizer (Inst); Pfizer (Inst)
 
Hossein Borghaei
Honoraria - Bristol-Myers Squibb; Celgene
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; EMD Serono; Genentech; Genmab; Lilly; Merck; Novartis; Pfizer; Trovagene
Research Funding - Celgene (Inst); Merck (Inst); Millennium (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene; Clovis Oncology; Genentech; Lilly; Merck; Novartis
Other Relationship - University of Pennsylvania
 
Matthew R. Zibelman
Consulting or Advisory Role - EMD Serono; Horizon Pharma
Research Funding - Bristol-Myers Squibb; Horizon Pharma
Patents, Royalties, Other Intellectual Property - US Patent No: 15/226,474 filed on 7/1/15 (Inst)
 
Daniel M. Geynisman
Consulting or Advisory Role - Exelixis; Novartis; Pfizer
Research Funding - Genentech (Inst); Merck (Inst); Millennium (Inst); Pfizer (Inst)
 
Jessica Ruth Bauman
No Relationships to Disclose